Evasion of CD8 + T Cells Is Critical for Superinfection by Cytomegalovirus
Top Cited Papers
- 2 April 2010
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 328 (5974) , 102-106
- https://doi.org/10.1126/science.1185350
Abstract
Cytomegalovirus Immune Evasion Strategy: Cytomegalovirus (CMV) infects a large percentage of the world's population. Most of those infected are asymptomatic; however, CMV is a substantial public health concern for immunocompromised individuals and neonates. CMV is unusual in that it can superinfect: it re-infects hosts who are already infected with the virus, even in the presence of a strong, specific immune response. Hansen et al. (p. 102 ; see the Perspective by Hengel and Koszinowski ) now find that in rhesus macaques, a good model for human CMV superinfection, CMV establishes superinfections by evading the immune response mediated by CD8 + T cells. A series of viral mutants deficient in expression of the US2-11 glycoproteins, which regulate antigen presentation to CD8 + T cells, revealed that, although able to establish the initial infection, these viral mutants were unable to superinfect. Depletion of CD8 + T cells from the monkeys allowed infection by the mutant viruses. These results highlight the difficulties in developing an effective protective vaccine against CMV itself, but suggest that CMV-based vectors may be useful in other vaccine efforts such as those against HIV.Keywords
This publication has 20 references indexed in Scilit:
- The Human Cytomegalovirus US10 Gene Product Delays Trafficking of Major Histocompatibility Complex Class I MoleculesJournal of Virology, 2002
- The Human Cytomegalovirus US8 Glycoprotein Binds to Major Histocompatibility Complex Class I ProductsJournal of Virology, 2002
- The HCMV Gene Products US2 and US11 Target MHC Class I Molecules for Degradation in the CytosolPublished by Springer Nature ,2002
- Intrauterine Transmission of Cytomegalovirus to Infants of Women with Preconceptional ImmunityNew England Journal of Medicine, 2001
- The human cytomegalovirus gene product US6 inhibits ATP binding by TAPThe EMBO Journal, 2001
- The Immunoevasive Function Encoded by the Mouse Cytomegalovirus Gene m152 Protects the Virus against T Cell Control in VivoThe Journal of Experimental Medicine, 1999
- Simultaneous infection of healthy people with multiple human cytomegalovirus strainsThe Lancet, 1998
- Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the DonorNew England Journal of Medicine, 1995
- Immunity Induced By Primary Human Cytomegalovirus Infection Protects Against Secondary Infection Among Women Of Childbearing AgeThe Journal of Infectious Diseases, 1995
- Protective Effects of Towne Cytomegalovirus Vaccine Against Low-Passage Cytomegalovirus Administered as a ChallengeThe Journal of Infectious Diseases, 1989